Skip to main content
. 2010 Oct 26;25(11):1553–1559. doi: 10.3346/jkms.2010.25.11.1553

Table 5.

Risk factors of VTE in general medical patients

graphic file with name jkms-25-1553-i005.jpg

*congenital thrombophilia such as antithrombin III deficiency or protein C or S deficiency, or acquired thrombophilia like antiphospholipid antibody syndrome.

VTE, venous thromboembolism; HRT, hormone replacement therapy; OCs, oral contraceptives; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; CHF, congestive heart failure; NYHA, New York Heart Association, VTE, venous thromboembolism.